From: Oncogenic viruses associated with vulva cancer in HIV-1 patients in Botswana
Negative | GP5+/6+ | HPV-18 | HPV-16 | HPV-45 | HPV-33 | HPV-31 | HPV-11 | HPV-6 | EBV | KSHV P1/P2 | KSHV F/R | JC |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | + | - | - | - | - | - | - | - | + | - | - | - |
2 | + | - | + | + | - | + | - | + | + | - | - | - |
3 | - | - | + | - | - | + | - | + | + | - | - | - |
4 | + | - | + | + | - | + | - | - | + | - | - | - |
5 | + | - | + | + | - | + | - | - | + | + | - | - |
6 | + | - | + | + | - | + | + | - | + | - | - | - |
7 | + | - | + | + | - | - | - | - | + | - | - | - |
8 | - | - | - | - | - | - | - | + | - | - | - | - |
9 | - | - | + | - | - | + | - | + | + | - | - | - |
Total | 67% | Â | 78% | 56% | Â | 67% | 11% | 44% | 89% | 11% | Â | Â |
Positive | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
1 | + | - | + | - | - | + | - | + | + | + | + | - |
2 | + | - | + | - | - | + | - | + | + | + | + | - |
3 | + | - | + | + | + | + | - | + | + | - | + | - |
4 | + | - | + | - | - | + | - | + | + | - | - | - |
5 | + | + | + | + | - | + | - | - | + | - | + | - |
6 | - | - | - | - | - | - | - | + | + | + | + | - |
7 | - | - | - | - | - | - | + | + | + | - | - | - |
8 | - | - | + | - | - | + | - | - | + | - | - | - |
9 | - | - | + | + | - | + | + | - | + | - | - | - |
10 | + | - | + | - | - | + | + | - | + | + | - | - |
11 | - | - | - | - | - | + | - | - | + | + | - | - |
12 | + | - | + | + | - | + | - | - | + | - | - | - |
13 | - | - | + | + | - | + | - | - | + | - | - | - |
Total | 54% | 8% | 77% | 39% | 8% | 85% | 23% | 46% | 100% | 39% | 39% | Â |
OR | 0.57 | 18.47 | 0.94 | 0.50 | 18.47 | 1.94 | 2.41 | 1.08 | 25.82 | 5.17 | 129.09 | NA |
CI | 0.32-1.02 | 1.05-324.5 | 0.48-1.83 | 0.28- 0.88 | 1.05- 324 | 0.94-4.01 | 1.10-5.27 | 0.62-1.89 | 1.50-444.6 | 2.45-10.8 | 7.7-2138.5 | NA |
P Value | 0.06 | 0.04 | 0.86 | Â 0.01 | 0.04 | 0.07 | 0.02 | 0.78 | 0.02 | <0.01 | <0.01 | NA |